1. HBW Insight

McNamara To Lead GSK’s Standalone Consumer Healthcare Business

 
• By Tom Gallen

Following a six month selection process, GSK has named Brian McNamara as CEO designate of its standalone Consumer Healthcare business, which will list on the London Stock Exchange next year.

Munich, Bavaria / Germany - May 19, 2018: Headquarters of GlaxoSmithKline GmbH & Co. KG in Munich, Germany - GSK is a British pharmaceutical company
• Source: Shutterstock

Brian McNamara will lead GlaxoSmithKline’s standalone Consumer Healthcare business when it launches in summer 2022.

CEO of GSK’s Consumer Healthcare division since October 2016, McNamara has been named CEO designate of the new, listed Consumer Healthcare company, securing the

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Leadership

More from HBW Insight